In response to dosing omalizumab in allergic asthma

被引：5
|
作者：
Jaffe, Jonathan S. [1 ]
Massanari, Marc
机构：
[1] Novartis Pharmaceut Corp, Exploratory Clin Dev, E Hanover, NJ USA
[2] Novartis Pharmaceut Corp, US Clin Dev & Med Affairs, E Hanover, NJ USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2007年 / 119卷 / 01期
关键词：
D O I：
10.1016/j.jaci.2006.10.026
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：255 / 256
页数：2
相关论文
共 50 条
  • [1] In response to dosing omalizumab in allergic asthma - Reply
    Hardin, Bryan D.
    Kelman, Bruce J.
    Saxon, Andrew
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : 256 - 257
  • [2] Response to Omalizumab in Black and White Patients with Allergic Asthma
    Szefler, Stanley J.
    Jerschow, Elina
    Yoo, Bongin
    Janampally, Pranathi
    Pazwash, Hooman
    Holweg, Cecile T. J.
    Hudes, Golda
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (11): : 4021 - 4028
  • [3] Treating allergic asthma with omalizumab
    Belliveau, Paul P.
    Lahoz, Monina R.
    DISEASE MANAGEMENT & HEALTH OUTCOMES, 2007, 15 (03) : 165 - 179
  • [4] Spotlight on Omalizumab in Allergic Asthma
    Lynne M. Bang
    Greg L. Plosker
    BioDrugs, 2004, 18 : 415 - 418
  • [5] Spotlight on omalizumab in allergic asthma
    Bang, LM
    Plosker, GL
    BIODRUGS, 2004, 18 (06) : 415 - 418
  • [6] Specific IgE Response and Omalizumab Responsiveness in Severe Allergic Asthma
    Tajiri, Tomoko
    Suzuki, Motohiko
    Kutsuna, Takeo
    Nishiyama, Hirono
    Ito, Keima
    Takeda, Norihisa
    Fukumitsu, Kensuke
    Kanemitsu, Yoshihiro
    Fukuda, Satoshi
    Umemura, Takehiro
    Ohkubo, Hirotsugu
    Maeno, Ken
    Ito, Yutaka
    Oguri, Tetsuya
    Takemura, Masaya
    Yoshikawa, Kosho
    Niimi, Akio
    JOURNAL OF ASTHMA AND ALLERGY, 2023, 16 : 149 - 157
  • [7] The Response To Treatment With Omalizumab In Patients With Severe, Persistent Allergic Asthma
    Mogal, R.
    Khachi, H.
    Barnes, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [8] Asthma with multiple allergic comorbidities is associated with complete response to omalizumab
    Sese, Lucile
    Schneider, Marion
    Bourgoin, Melisande
    Saint-Pierre, Philippe
    Lambert, Nathalie
    Guiddir, Tamazoust
    Couderc, Remi
    Amat, Flore
    Just, Jocelyne
    CLINICAL AND EXPERIMENTAL ALLERGY, 2019, 49 (05): : 733 - 735
  • [9] Predicting and evaluating response to omalizumab in patients with severe allergic asthma
    Bousquet, J.
    Rabe, K.
    Humbert, M.
    Chung, K. F.
    Berger, W.
    Fox, H.
    Ayre, G.
    Chen, H.
    Thomas, K.
    Blogg, M.
    Holgate, S.
    RESPIRATORY MEDICINE, 2007, 101 (07) : 1483 - 1492
  • [10] SEVERE ASTHMA WITH MULTIPLE ALLERGIC DISORDERS: FAVORABLE RESPONSE TO OMALIZUMAB
    Bertozzi, T.
    Lang, P.
    Frieri, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A40 - A41
12345